Stephen Carey
Director of Finance/CFO at ANI PHARMACEUTICALS, INC.
Net worth: 12 M $ as of 2024-03-30
Profile
Stephen P.
Carey is currently the Chief Financial Officer & Senior VP-Finance at ANI Pharmaceuticals, Inc. Prior to his current position, he worked as the Chief Accounting Officer, Senior VP & Controller at Endo Generics Holdings, Inc. from 2007 to 2015.
Mr. Carey obtained his undergraduate degree from Montclair State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-09 | 166,968 ( 0.79% ) | 12 M $ | 2024-03-30 |
Stephen Carey active positions
| Companies | Position | Start |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Director of Finance/CFO | 2016-05-05 |
Former positions of Stephen Carey
| Companies | Position | End |
|---|---|---|
| PAR PHARMACEUTICAL COMPANIES, INC. | Comptroller/Controller/Auditor | 2015-09-30 |
Training of Stephen Carey
| Montclair State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Stephen Carey
